Ultragenyx Pharmaceutical Inc

Common Name
Ultragenyx Pharmaceutical
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,294
Ticker
RARE
Exchange
NASDAQ/NGS
Description
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company that focuses on the development and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases. The com...

Disclosures of Ultragenyx Pharmaceutical

Explore Ultragenyx Pharmaceutical's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Ultragenyx Pharmaceutical's official channels and fully traceable to its official company sources.

The table below lists all of Ultragenyx Pharmaceutical's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
10-K2024
Impact Report2024
Financial & Extra-Financial Disclosure2024
Financial & Extra-Financial Disclosure2023
Corporate Responsibility Report (CRR)2023
10-K2023
10-K2022
10-K2022
10-K2021
Financial & Extra-Financial Disclosure2021
ESG Report2021
10-K2020
Financial & Extra-Financial Disclosure2020
10-K2019
Financial & Extra-Financial Disclosure2019
10-K2018
Financial & Extra-Financial Disclosure2018
10-K2017
Financial & Extra-Financial Disclosure2017
10-K2016
Financial & Extra-Financial Disclosure2016
10-K2015
Financial & Extra-Financial Disclosure2015
10-K2014
Financial & Extra-Financial Disclosure2014
10-K2013
Financial & Extra-Financial Disclosure2013
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?